Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial

Background & aims: To assess the possible association between a validated Dietary Inflammatory Index (DII) and specific dietary components with suitable non-invasive markers of liver status in overweight and obese subjects within the PREDIMED study. Methods: A cross-sectional study encompassing...

Descripción completa

Detalles Bibliográficos
Autores: Cantero, Irene, Abete, Itziar, Babio, Nancy, Aros, Fernando, Corella, Dolores, Estruch, Ramon, Fito, Montserrat, Hebert, James R, Angel Martinez-Gonzalez, M, Pinto, Xavier, Puy-Portillo, María, Ruiz-Canela, Miguel, Shivappa, Nitin, Warnberg, Julia, Gomez-Gracia, Enrique, Tur, Josep A, Salas-Salvado, Jordi, Angeles Zulet, M, Alfredo Martinez, J
Tipo de recurso: artículo
Fecha de publicación:2018
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/22638
Acceso en línea:https://hdl.handle.net/20.500.12105/22638
Access Level:acceso abierto
Palabra clave:Liver
Diet
Inflammation
NAFLD
Obesity
Dieta Mediterránea
Registros de Dieta
Biomarcadores
Femenino
Enfermedad del Hígado Graso no Alcohólico
Dieta
Factor de Necrosis Tumoral alfa
Proteína C-Reactiva
Masculino
Estudios Transversales
Cooperación del Paciente
Interleucinas
Humanos
Persona de Mediana Edad
Obesidad
Inflamación
Anciano
Encuestas y Cuestionarios
Sobrepeso
Adiposidad
Aged
Humans
C-Reactive Protein
Middle Aged
Non-alcoholic Fatty Liver Disease
Cross-Sectional Studies
Interleukins
Male
Biomarkers
Patient Compliance
Tumor Necrosis Factor-alpha
Female
Adiposity
Diet, Mediterranean
Overweight
Diet Records
Descripción
Sumario:Background & aims: To assess the possible association between a validated Dietary Inflammatory Index (DII) and specific dietary components with suitable non-invasive markers of liver status in overweight and obese subjects within the PREDIMED study. Methods: A cross-sectional study encompassing 794 randomized overweight and obese participants (mean +/- SD age: 67.0 +/- 5.0 y, 55% females) from the PREDIMED (PREvencion con Dleta MEDiterranea) trial was conducted. DII is a validated tool evaluating the effect of diet on six inflammatory biomarkers (IL-1b, IL-4, IL-6, IL-10, TNF-alpha and C-reactive protein). Furthermore, a validated 137-item food-frequency-questionnaire was used to obtain the information about the food intake. In addition, anthropometric measurements and several non-invasive markers of liver status were assessed and the Fatty Liver Index (FLI) score was calculated. Results: A higher DII and lower adherence to Mediterranean diet (MeDiet) were associated with a higher degree of liver damage (FLI > 60) in obese as compared to overweight participants. Furthermore, the DII score was positively associated with relevant non-invasive liver markers (ALT, AST, GGT and FLI) and directly affected FLI values. Interestingly, a positive correlation was observed between liver damage (>50th percentile FLI) and nutrients and foods linked to a pro-inflammatory dietary pattern. Conclusions: This study reinforced the concept that obesity is associated with liver damage and revealed that the consumption of a pro-inflammatory dietary pattern might contribute to obesity and fatty liver disease features. These data suggest that a well-designed precision diet including putative anti-inflammatory components could specifically prevent and ameliorate non-alcoholic fatty liver manifestations in addition to obesity.